Posts Tagged ‘PFE’

Icagen Inc. (ICGN) takes flight on hint of Pfizer takeover

Monday, June 27th, 2011

Icagen Inc. (Nasdaq: ICGN) shares rocketed 113.8% to $5.13 after drug manufacturer Pfizer Inc. (NYSE: PFE) said in a regulatory filing late Friday that it was looking at a possible strategic alliance with the biopharmaceutical company. Volume for Icagen totaled 1.8 million shares in the early trading hours of Monday, compared to an all-day average of 71,000.

A news release was issued soon after the market closed on Friday, June 24. In the release, Icagen put out a statement in which it acknowledged that it is currently engaged in preliminary discussions with Pfizer regarding a potential strategic transaction, but, quote “no definitive agreement has been reached.

“There can be no assurance that any agreement will be reached,” the statement continued, “or that a transaction will be consummated. Icagen does not plan to make future announcements with respect to this matter unless and until its Board of Directors has approved a specific transaction or an extension or other modification of the existing collaboration agreement and it has entered into a definitive agreement or the current discussions have terminated.”

Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels.

EL up, PFE active, FBN floored

Thursday, February 3rd, 2011

Estee Lauder Cos. (NYSE: EL) shares gained 14.8 percent to $92.49, on volume of 4.9 million – or quadruple its daily average, after the cosmetics maker raised its fiscal-year forecast.

Pfizer Inc. (NYSE: PFE) was busy on the markets Thursday, trading in 52.5 million shares, beating out its daily average of 47 million. Share prices marched again 1.4 percent to $19.22, although biotechs in general were flat to downward Thursday.

Furniture Brands International (NYSE: FBN) lost 17.7 percent of its price strength Thursday to $3.78. Volume for the stock was 4.9 million shares, or more than 12 times its normal daily average, after reporting Thursday a net Q4 loss of $44.7 million, still an improvement from the quarterly loss of $65 million it suffered a year earlier.

ZANE up, PFE trades, HA falls

Wednesday, February 2nd, 2011

Zanett Inc. (Nasdaq: ZANE) shares zoomed 28.8 percent to $1.52. Volume for the stock was 1.6 million, overwhelming a daily average of nearly 54,000, after after announcing Parkview Health will implement its Zanett Clinical Online Delivery System.

Pfizer Inc. (NYSE: PFE) traded in 69.8 million shares, outdistancing its daily average of 46.5 million. Prices for PFE sagged 0.2 percent to $18.98, over word that laid-off PFE employees will get less severance than anticipated.

Hawaiian Holdings Inc. (Nasdaq: HA) shares were off 8.4 percent to $6.99. Volume for the stock was 3.2 million, dwarfing a daily average of 403,000 after Stifel Nicolaus downgraded the parent company of Hawaiian Airlines from buy to hold.

WG wild and good, PFE popular, CPF reacts to proposed split

Monday, January 24th, 2011

Willbros Group Inc.(NYSE: WG) shares rose 15.2% to $11.47 Monday. Volume for the stock was 1.4 million, swallowing up a full-day average of 579,364, after Johnson Rice hiked its view of the oil-industry contractor to overweight from equal-weight.

Pfizer (Nasdaq: PFE) dealt in 36.8 million shares Monday, just shy of its full-day average of 45.4 million. Share prices were up 0.3 percent to $18.42, after Mylan Inc. said Monday it is now shipping a generic version of Pfizer Inc.’s heartburn drug Protonix.

Central Pacific Financial Corporation (NYSE: CPF) went south 10.6 percent to $1.61 Monday. Volume for the stock was 584,318 shares, doubling its daily average, after Friday letting out word of plans for a reverse stock split.

ZBB zips along, PFE has healthy volume, ICGN downward

Thursday, January 20th, 2011

ZBB Energy Corporation (AMEX: ZBB) gained 14.8 percent Thursday to $1.24, on volume of 1,384,173 shares, more than four times its full-day average, after signing lucrative contracts in China.

Pfizer Inc. (NYSE: PFE) dealt in 43,708,033 shares, to within a few aces of its full-day average of 45,414,700. Share prices were flat at $18.27

Icagen Inc. (Nasdaq: ICGN) dipped 17 percent to $2.44. Volume was 1,761,812 shares, four times its daily average.